- Home
- MNKD vs BCRX Comparison
MNKD vs BCRX Comparison
Compare MNKD & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNKD | BCRX |
|---|---|---|
| Founded | 1991 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2004 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MNKD | BCRX |
|---|---|---|
| Price | $5.68 | $7.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 12 |
| Target Price | $10.08 | ★ $20.08 |
| AVG Volume (30 Days) | 3.3M | ★ 3.7M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.47 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | $313,787,000.00 | ★ $599,816,000.00 |
| Revenue This Year | $21.54 | $39.98 |
| Revenue Next Year | $22.21 | $7.12 |
| P/E Ratio | $57.92 | ★ N/A |
| Revenue Growth | 17.43 | ★ 45.38 |
| 52 Week Low | $3.38 | $6.00 |
| 52 Week High | $6.68 | $11.31 |
Technical Indicators
Market Signals| Indicator | MNKD | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.22 | 60.75 |
| Support Level | $5.56 | $7.52 |
| Resistance Level | $6.12 | $7.77 |
| Average True Range (ATR) | 0.17 | 0.31 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 20.51 | 88.20 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.